Aligos Therapeutics (NASDAQ:ALGS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently ...

The latest price target for Aligos Therapeutics (NASDAQ:ALGS) was reported by HC Wainwright & Co. on March 31, 2025. The analyst firm set a price target for $70.00 expecting ALGS to rise to within ...

At close: April 1 at 4:00:01 PM EDT ...

As of 2:57:04 PM EDT. Market Open. Sustainability data is currently not available for ALGS.

Welcome to the September edition of Changing Faces. September ushered in a wave of significant appointments across the pharmaceutical and biotechnology industries, with companies from big pharma ...

A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a ...

An advantage of stocks under $10 is that some of these stocks can make a good choice for short and medium-term trading strategies. Buying shares of a lower dollar amount also limits your exposure ...